Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

NCT02173665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1356 BS - Powder in bottle (PIB)
DRUG: BI 1356 BS - Tablet
DRUG: Placebo

Sponsor

Boehringer Ingelheim